| Literature DB >> 35528072 |
Yingfang Lu1, Yinning Chen2, Yulin Wu1, Huili Hao1, Wenjing Liang3, Jun Liu4, Riming Huang1.
Abstract
Unsaturated fatty acids (UFAs) are an important category of monounsaturated and polyunsaturated fatty acids with nutritional properties. These secondary metabolites have been obtained from multitudinous natural resources, including marine organisms. Because of the increasing numerous biological importance of these marine derived molecules, this review covers 147 marine originated UFAs reported from 1978 to 2018. The review will focus on the structural characterizations, biological properties, proposed biosynthetic processes, and healthy benefits mediated by gut microbiota of these marine naturally originated UFAs. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35528072 PMCID: PMC9074775 DOI: 10.1039/c9ra08119d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Monounsaturated fatty acids from marine organisms
| Number | Names | Bioactivities | Sources | Reference(s) |
|---|---|---|---|---|
| 1 | 10-Tricosenoic acid | — |
|
|
| 2 | (6 | — |
|
|
| 3 | Not given | — |
|
|
| 4 | Not given | — |
|
|
| 5 | Not given | — |
|
|
| 6 | Not given | Antiinflammatory properties |
|
|
| 7 | Not given | — |
|
|
| 8 | Not given | — |
|
|
| 9 | Not given | — |
|
|
| 10 | (2 | — |
|
|
| 11 | Not given | — |
|
|
| 12 | Not given | — |
|
|
| 13 | Seco-patulolide | — |
|
|
| 14 | Not given | — |
|
|
Fig. 1Structures of monounsaturated fatty acids from marine organisms.
Linear polyunsaturated fatty acids from marine organisms
| Number | Names | Bioactivities | Sources | Reference(s) |
|---|---|---|---|---|
| 15 | Not given | — |
|
|
| 16 | Not given | Antimicrobial |
|
|
| 17 | Carduusyne A | — |
|
|
| 18 | Petroformynic acid | — |
|
|
| 19 | (5 | — |
|
|
| 20 | (5 | — |
|
|
| 21 | 5( | — |
|
|
| 22 | (5 | Inhibiting growth of the green alga |
|
|
| 23 | (4 | — |
|
|
| 24 | 10,15-Eicosadienoic acid | — |
|
|
| 25 | (5 | — |
|
|
| 26 | (5 | — |
|
|
| 27 | (5 | — |
|
|
| 28 | (5 | — |
|
|
| 29 | (5 | — |
|
|
| 30 | (5 | — |
|
|
| 31 | 7,11,14,17-Eicosatetraenoic acid | Anti-inflammatory |
|
|
| 32 | 7,13-Eicosadienoic acid | — |
|
|
| 33 | 7,13,17-Eicosatrienoic acid | — |
|
|
| 34 | 9,15,19-Docosatrienoic acid | — |
|
|
| 35 | 4,9,15,19-Docosatetraenoic acid | — |
|
|
| 36 | (7 | — |
|
|
| 37 | 4,7,10,13,16,19,22,25-Octacosaoctaenoic acid | — | Marine dinoflagellate species |
|
| 38 | 7,11-Tetradecadiene-5,9-diynoic acid | — | Marine dinoflagellate species |
|
Fig. 2Structures of linear chain polyunsaturated fatty acids from marine organisms.
Fig. 6Pathway for the biosynthesis of long chain polyunsaturated fatty acids in microalgae.
Fig. 7Impact of SFA and PUFA on gut microbiota and metabolic regulation.
Fig. 8The distribution of UFAs reported from marine organisms.
Fig. 9Origin of branched monounsaturated fatty acids.
Fig. 10Origin of linear chain polyunsaturated fatty acids.
Fig. 11Origin of branched chain polyunsaturated fatty acids.
Branched chain polyunsaturated fatty acids from sponges
| Number | Names | Bioactivities | Sources | Reference(s) |
|---|---|---|---|---|
| 39 | Not given | — |
|
|
| 40 | Not given | — |
|
|
| 41 | Not given | — |
|
|
| 42 | Not given | — |
|
|
| 43 | ( | — |
|
|
| 44 | ( | — |
|
|
| 45 | (5 | — |
|
|
| 46 | 5,8,10,14,17-Eicosapentaenoic acid | — |
|
|
| 47 | Not given | — |
|
|
| 48 | 4,7,10,12,16,19-Docosahexaenoic acid | — |
|
|
| 49 | Not given | — |
|
|
| 50 | 5,9-Eicosadienoic acid | — |
|
|
| 51 | 5,9-Eicosadienoic acid | — |
|
|
| 52 | Petrosolic acid | Inhibited HIV reverse transcriptase |
|
|
| 53 | Corticatic acid A | Antifungal |
|
|
| 54 | Corticatic acid B | Antifungal |
|
|
| 55 | Corticatic acid C | Antifungal |
|
|
| 56 | Nepheliosyne A | — |
|
|
| 57 | Triangulynic acid | Against leukemia and colon tumour lines |
|
|
| 58 | Pellynic acid | Inhibited inosine monophosphate dehydrogenase |
|
|
| 59 | Aztequynol A | — |
|
|
| 60 | Aztequynol B | — |
|
|
| 61 | Osirisyne A | — |
|
|
| 62 | Osirisyne B | — |
|
|
| 63 | Osirisyne C | — |
|
|
| 64 | Osirisyne D | — |
|
|
| 65 | Osirisyne E | — |
|
|
| 66 | Osirisyne F | — |
|
|
| 67 | Aikupikanyne F | — |
|
|
| 68 | Haliclonyne | — |
|
|
| 69 | Callyspongynic acid | α-glucosidase inhibitor |
|
|
| 70 | Corticatic acid D | Geranylgeranyltransferase type I inhibitor |
|
|
| 71 | Corticatic acid E |
|
| |
| 72 | (5 | Cytotoxic activity against mouse Ehrlich carcinoma cells and a hemolytic effect on mouse erythrocytes |
|
|
| 73 | Stellettic acid C | Exhibited marginal to moderate toxicity to five human tumour cell lines |
|
|
| 74 | Not given | Cytotoxic to human leukemia cells |
|
|
| 75 | Petroformynic acid B | Cytotoxic |
|
|
| 76 | Petroformynic acid C |
|
| |
| 77 | Heterofibrin A1 | Inhibited lipid droplet formation |
|
|
| 78 | Officinoic acid B | — |
|
|
| 79 | Fulvyne A | Against a chloramphenicol-resistant strain of |
|
|
| 80 | Fulvyne B |
|
| |
| 81 | Fulvyne C |
|
| |
| 82 | Fulvyne D |
|
| |
| 83 | Fulvyne E |
|
| |
| 84 | Fulvyne F |
|
| |
| 85 | Fulvyne G |
|
| |
| 86 | Fulvyne H |
|
| |
| 87 | Fulvyne I |
|
| |
| 88 | Petrosynic acid A | — |
|
|
| 89 | Petrosynic acid B | — |
|
|
| 90 | Petrosynic acid C | — |
|
|
| 91 | Petrosynic acid D | — |
|
|
Branched chain polyunsaturated fatty acids from algae
| Number | Names | Bioactivities | Sources | Reference(s) |
|---|---|---|---|---|
| 92 | (10 | — |
|
|
| 93 | (5 | Antimicrobial |
|
|
| 94 | (2 | Antimicrobial | L. |
|
| 95 | Acyclicditerpene | — |
|
|
| 96 | Ptilodene | Inhibited both 5-lipoxygenase and Na+/K+A TPase |
|
|
| 97 | 12-( | Inhibitor of platelet aggregation |
|
|
| 98 | 9-Hydroxypentaenoic acid | — |
|
|
| 99 | Turbinaric acid | Cytotoxic |
|
|
| 100 | (12 | Modulated fMLP-induced superoxide anion generation in human neutrophils; inhibited the conversion of arachidonic acid to lipoxygenase products by human neutrophils; inhibited the functioning of the dog kidney Na+/K+ ATPase |
|
|
| 101 | (12 |
|
| |
| 102 | (10 |
|
| |
| 103 | (5 | — |
|
|
| 104 | (5Z,8Z,10E,12R,13S,14Z)-12,13-dihydroxyeicosa-5,8,10,14-tetraenoic acid | — |
|
|
| 105 | (6 | — |
|
|
| 106 | (9 | — |
|
|
| 107 | (6Z,9E,11E,13E)-9-formyl- 15-oxoheptadeca-6,9,11,13-tetraenoic acid | — |
|
|
| 108 | (10 | — |
|
|
| 109 | (10 | — |
|
|
| 110 | (9 | — |
|
|
| 111 | (9 | — |
|
|
| 112 | (9 | — |
|
|
| 113 | (9 | — |
|
|
| 114 | Not given | — |
|
|
| 115 | Not given | — |
|
|
| 116 | 9,11-Dodecadienoic acid | — |
|
|
| 117 | (13 | — |
|
|
| 118 | (12 | — |
|
|
| 119 | (6 | — |
|
|
| 120 | Hepoxilin B3 | — |
|
|
| 121 | Hepoxilin B3 | — |
|
|
| 122 | Hepoxilin B4 | — |
|
|
| 123 | Hepoxilin B4 | — |
|
|
| 124 | (5 | — |
|
|
| 125 | (5 | — |
|
|
| 126 | (6 | — |
|
|
| 127 | (6 | — |
|
|
| 128 | 8,12-Octadecadienoic acid | — |
|
|
| 129 | (8 | — |
|
|
Branched chain polyunsaturated fatty acids from Coelenterate, Marine fungus, Arthropoda, Bacterium
| Number | Names | Bioactivities | Sources | Reference(s) |
|---|---|---|---|---|
| 130 | Leiopathic acid | — |
|
|
| 131 | 5,9,11,14,17-Eicosapentaenoic acid | — |
|
|
| 132 | 5,9,11,14,17-Eicosapentaenoic acid | — |
|
|
| 133 | (11 | — |
|
|
| 134 | (5 | Inhibited the growth of Gram positive bacteria |
|
|
| 135 | 6,9,12,16,18-Tetracosapentaenoic acid | Inhibited tube-formation in a human endothelial cell line model of angiogenesis |
|
|
| 136 | Dendryphiellic acid A | — |
|
|
| 137 | Dendryphiellic acid B | — |
|
|
| 138 | Curvulalic acid | — |
|
|
| 139 | 2,4-Decadienoic acid | — |
|
|
| 140 | (5Z,8 | — |
|
|
| 141 | 8,13-Dihydroxyeicosapentaenoic acid | A muscle stimulatory factor in the barnacle |
|
|
| 142 | (9Z,12Z)-7-hydroxyoctadeca-9,12-dien-5-ynoic acid | Ichthyotoxic |
|
|
| 143 | Macrolactic acid | — | Unidentified Gram-positive bacterium |
|
| 144 | Isomacrolactic acid | — | Unidentified Gram-positive bacterium |
|
| 145 | Ieodomycin C | Antimicrobial |
|
|
| 146 | Ieodomycin D |
|
| |
| 147 | Linieodolide B | Antibacterial; antifungal |
|
|